Integrating breast cancer genetics into clinical practice

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Traditional breast cancer management relies on clinicopathological factors.
• Advances in breast cancer genetics have yet to significantly impact clinical care.
• Simple genetic markers are used, but molecular profiling offers deeper insights.

Purpose of the Study:

• To review the current and future applications of genetics and genomics in breast cancer management.
• To explore the impact of gene expression profiling on risk stratification and personalized therapy.
• To discuss limitations and realistic expectations for genomic approaches in breast cancer.

Main Methods:

• Review of current literature on breast cancer genetics and genomics.
• Discussion of high-throughput gene expression microarrays and their role in developing gene signatures.
• Analysis of prognostic and predictive multigene assays.

Main Results:

• Gene expression microarrays reveal breast cancer's molecular heterogeneity.
• Development of prognostic and predictive gene signatures is a key outcome.
• Studies are ongoing to validate and implement these multigene assays.

Conclusions:

• Genomic technologies are advancing breast cancer risk stratification.
• Personalized, patient-tailored therapy is a projected future benefit.
• Careful consideration of current limitations and realistic expectations is crucial for integrating genomics into clinical practice.